"I happen to agree with that, and I happen to have been a strong supporter of that."
"I believe strongly we must address the rising issue of children obesity in this country."
"How do you assure us that these voluntary guidelines will not become grafted into the law?"
"Hon. John D. Dingell, a Representative in Congress from the State of Michigan, prepared statement."
"Do you have authority at FDA or at HHS to waive any of the requirements with regard to efficacy, good manufacturing practices, or safety, yes or no, in the event of shortage?"
"It is my understanding that the FDA has been working to address shortages of medically necessary drugs."
"I have got some legislation to address that and I hope that we will be shortly addressing it here in this committee."
"This is a matter on which I have worked with the gentleman, my colleague Mr. Shimkus."
"I have a bill that would require manufacturers to maintain records establishing where the drug and its raw materials were produced."
"At the end of the day, American consumers and patients are facing 3 problems: 1) the drugs, they need to be available and affordable; 2) are there drugs they need safe; and 3) are they efficacious? Do..."
"I believe that agency has documented that fact over the course of 3 years and two administrations, one of each, Republican and Democratic."
"I hope that we don't take the failure, for whatever reason, of this project to mean that all renewable energy projects are bad investments."